|
|
 |
SENSEX
|
 |
252.15
|
1.02%
|
25003.05
|
|
|
NIFTY
|
 |
746.95
|
0.92%
|
82188.99
|
|
|
Nasdaq
|
 |
231.50
|
1.20%
|
19529.95
|
|
|
Nikkei 225
|
 |
187.12
|
0.50%
|
37741.61
|
|
|
FTSE 100
|
 |
26.90
|
0.31%
|
8837.90
|
|
|
 |
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Private |
BSE Code |
540222
|
ISIN Demat |
INE947Q01028
|
Book Value (Rs) |
84.10
|
|
NSE Code |
LAURUSLABS
|
Dividend Yield % |
0.19
|
Market Cap (Rs) |
346295.72
|
|
TTM PE(x) |
91.04
|
TTM EPS(Rs) |
7.05
|
Face Value(Rs.) |
2
|
|
|
|
|
|
|
Incorporation Year
|
19-09 2005
|
Registered Office
|
Laurus Enclave, Plot Office 01,Edulapaka Bonangi Village, Parawada,Mandal, Anakapalli, Vishakhapatnam, Andhra Pradesh-531021 .
|
ISINNO
|
INE947Q01028
|
Phone
|
0891 6821101 / 1102
|
E-mail
|
info@lauruslabs.com |
URL
|
www.lauruslabs.com |
Industry
|
Pharmaceuticals & Drugs
|
Chairman
|
Ravindranath Kancherla
|
Managing Director
|
|
Company Secretary
|
G Venkateswar Reddy
|
Listing
|
BSE,NSE
|
|
|
|
|
|
|
|
|
|
|
|